Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “lung cancer”
- Dose-Escalation of MNPR-101-PCTA-177Lu in Solid TumorsActive Not Recruiting
Sponsor: Monopar Therapeutics
Solid Tumor, Adult · Bladder Cancer · Urothelial Carcinoma · Triple-negative Breast Cancer
Australia
Sponsor: AstraZeneca
Stomatitis
United States
Sponsor: TRIANA Biomedicines, Inc.
ALK-positive NSCLC · ALK-Positive Lung Cancer · ALK-positive Non-small Cell Lung Cancer
United States, Australia
- Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLCActive Not Recruiting
Sponsor: AstraZeneca
Lung Cancer
China
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Patients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma )
France
Sponsor: Daiichi Sankyo
SCLC · Extensive-stage Small Cell Lung Cancer
United States
- A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)Recruiting
Sponsor: Merck Sharp & Dohme LLC
Lung Neoplasm Malignant
United States, Brazil, Chile, China, Germany +6 more
Sponsor: Sensei Biotherapeutics, Inc.
Solid Tumor, Adult · Advanced Solid Tumor · Head and Neck Cancer · Breast Cancer
United States
Sponsor: Eikon Therapeutics
Non Small Cell Lung Cancer (Squamous or Non Squamous) · Stage 4 NSCLC
United States, Australia, Spain
Sponsor: Memorial Sloan Kettering Cancer Center
Neuroendocrine Cancer · Small Cell Lung Cancer · Small Cell Lung Cancer ( SCLC )
United States
Sponsor: BioNTech SE
Advanced Solid Tumor
United States, Australia, Belgium, China, Germany +4 more
- JIN-A02 Plus Amivantamab in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI FailureNot Yet Recruiting
Sponsor: Yonsei University
Carcinoma · Non-Small-Cell Lung
- A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid TumorsRecruiting
Sponsor: Pierre Fabre Medicament
Solid Tumor, Adult · Non-small Cell Lung Cancer · Melanoma
United States, Australia, China, France, Italy +2 more
Sponsor: Göteborg University
Non-Small Cell Carcinoma of Lung
Sweden
Sponsor: The Third Xiangya Hospital of Central South University
NSCLC · Sintilimab · Adaptive Radiotherapy
China
- Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation ToolActive Not Recruiting
Sponsor: OHSU Knight Cancer Institute
Lung Carcinoma
United States
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer
China
Sponsor: Merck Sharp & Dohme LLC
Malignant Neoplasm
United States, Chile, China, Finland, Greece +8 more
Sponsor: Fate Therapeutics
Non-Small Cell Lung Cancer · Colorectal Cancer · Breast Cancer · Ovarian Cancer
United States
Sponsor: Alliance for Clinical Trials in Oncology
Lung Non-Small Cell Carcinoma
United States
- DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine CancersNot Yet Recruiting
Sponsor: Boehringer Ingelheim
Small Cell Lung Cancer · Large Cell Neuroendocrine Lung Carcinoma · Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology · Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
United States, Australia, Belgium, China, France +6 more
- A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor NaiveActive Not Recruiting
Sponsor: Incyte Corporation
Advanced Solid Tumor
Brazil, China, Georgia, Greece, Hungary +4 more
Sponsor: Memorial Sloan Kettering Cancer Center
Invasive Ductal Breast Carcinoma · Invasive Ductal Breast Carcinoma Stage IV · Lobular Breast Carcinoma · Lobular Breast Carcinoma Stage IV
United States
Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Non-small Cell Lung Caner · KRAS-mutated · Metastasis · Previous Treamted
China
Sponsor: ETOP IBCSG Partners Foundation
Extensive Stage Lung Small Cell Cancer
France, Greece, Italy, Spain, Switzerland